Exponent (NASDAQ: EXPO) CEO sells 1,737 shares after option exercise
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Exponent Inc. reported that CEO Catherine Corrigan exercised non-qualified stock options for 2,379 shares of common stock at $29.05 per share and on the same date sold 1,737 shares at $62.7776 per share to cover the option exercise price and taxes. After these trades, she directly held 115,771 common shares, and the transactions were effected under a Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 1,737 shares ($109,045)
Net Sell
3 txns
Insider
Corrigan Catherine
Role
Chief Executive Officer
Sold
1,737 shs ($109K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) | 2,379 | -- | -- |
| Exercise | Common Stock | 2,379 | $29.05 | $69K |
| Sale | Common Stock | 1,737 | $62.7776 | $109K |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 2,379 shares (Direct);
Common Stock — 117,508 shares (Direct)
Footnotes (1)
- Stock sale was to cover the option exercise price and taxes. The stock option becomes exercisable in four equal annual installments. Not applicable.
Key Figures
Shares sold: 1737.0000 shares
Sale price: 62.7776 USD per share
Shares after sale: 115771.0000 shares
+4 more
7 metrics
Shares sold
1737.0000 shares
Common shares sold on 2026-07-15 by CEO Catherine Corrigan
Sale price
62.7776 USD per share
Price received per share for 1,737 common shares sold
Shares after sale
115771.0000 shares
Direct common stock holdings following the reported sale transaction
Options exercised
2379.0000 shares
Common shares acquired through exercise of non-qualified stock options
Option exercise price
29.0500 USD per share
Exercise price for the non-qualified stock option converted into common shares
Shares after exercise
117508.0000 shares
Direct common stock holdings immediately following the option exercise
Option expiration
2027-02-16
Expiration date of the non-qualified stock option exercised
Key Terms
Rule 10b5-1 trading plan, Non-Qualified Stock Option, exercise price, open market or private transaction, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The filing notes the trades were effected under a Rule 10b5-1 trading plan."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Non-Qualified Stock Option financial
"Security title listed as Non-Qualified Stock Option (right to buy)."
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
exercise price financial
"Stock sale was to cover the option exercise price and taxes."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
open market or private transaction financial
"Transaction code description states Sale in open market or private transaction."
derivative security financial
"Transaction code description notes Exercise or conversion of derivative security."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did Exponent (EXPO) report for CEO Catherine Corrigan?
Exponent reported that CEO Catherine Corrigan exercised 2,379 stock options and sold 1,737 common shares on July 15, 2026. The sale was described as covering the option exercise price and taxes, and the trades were made under a Rule 10b5-1 trading plan.
What options did Exponent (EXPO)'s CEO exercise on July 15, 2026?
On July 15, 2026, the CEO exercised a non-qualified stock option for 2,379 underlying common shares at an exercise price of $29.05 per share. The related option position had an expiration date of February 16, 2027, according to the reported data.
Were Catherine Corrigan’s Exponent (EXPO) trades made under a Rule 10b5-1 plan?
Yes. The filing indicates the trades were executed under a Rule 10b5-1 trading plan. This designation means the transactions followed a pre-arranged plan for selling or acquiring shares, which can reduce the significance of their timing as an informational signal.